Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other Working Capital Changes (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Other Working Capital Changes data on record, last reported at $856000.0 in Q3 2025.

  • For Q3 2025, Other Working Capital Changes rose 104.0% year-over-year to $856000.0; the TTM value through Sep 2025 reached $21.0 million, down 66.33%, while the annual FY2024 figure was -$73000.0, 100.09% down from the prior year.
  • Other Working Capital Changes reached $856000.0 in Q3 2025 per ASMB's latest filing, down from $8.5 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $83.6 million in Q4 2023 and bottomed at -$21.4 million in Q3 2024.
  • Average Other Working Capital Changes over 5 years is $4.4 million, with a median of -$383000.0 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 5290.12% in 2023, then crashed 1934.34% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $1.7 million in 2021, then plummeted by 192.16% to -$1.6 million in 2022, then surged by 5290.12% to $83.6 million in 2023, then crashed by 74.76% to $21.1 million in 2024, then plummeted by 95.94% to $856000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $856000.0 in Q3 2025, $8.5 million in Q2 2025, and -$9.4 million in Q1 2025.